Tandem Health announced on September 14, 2026, that it has raised $100 million in Series B funding led by the Scaleup Europe Fund, managed by EQT. The Stockholm-based company said it is the first healthcare AI company the fund has backed, and that existing investors Kinnevik, Northzone, Amino Collective and Visionaries also participated in the round. The Series B follows a $50 million Series A in 2025 and brings Tandem's total funding to $160 million, according to the company. The Scaleup…
Read the original article:
